name: [X]Unspecified fall, occurrence at unspecified place


name: Deprecated Cerebroside sulfatase [Enzymatic activity/mass] in Tissue


name: Deprecated BCL2 gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method


name: Deprecated Basophils/100 leukocytes in Body fluid by Manual count


name: Deprecated Bilirubin [Mass/volume] in Body fluid


name: Deprecated CD23 cells/100 cells in Unspecified specimen


name: Deprecated CD235a cells/100 cells in Unspecified specimen


name: Deprecated CD30 Ag [Presence] in Tissue by Immune stain


name: Deprecated CD5 cells [#/volume] in Blood


name: Deprecated CD5+CD19+ cells [#/volume] in Blood


name: Deprecated CD56 cells/100 cells in Unspecified specimen


name: Deprecated CFTR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal


name: Deprecated Cytomegalovirus Ab [Titer] in Serum


name: Deprecated Cytomegalovirus Ab [Titer] in Serum by Latex agglutination


name: Deprecated Carbon dioxide [Molecules/volume] in Body fluid


name: Deprecated Campylobacter sp identified in Unspecified specimen by Organism specific culture


name: Deprecated Casts [#/area] in Urine sediment by Microscopy high power field


name: Deprecated Cefepime [Susceptibility] by Disk diffusion (KB)


name: Deprecated Cefpirome [Susceptibility] by Disk diffusion (KB)


name: Deprecated Chlamydia sp Ab [Titer] in Serum by Complement fixation


name: Deprecated Cholesterol [Mass/volume] in Body fluid


name: Deprecated Cholesterol [Mass/volume] in Pleural fluid


name: Deprecated Benzoylmethylecgonine [Mass/volume] in Urine


name: Deprecated Collection duration of Urine - time unspecified


name: Deprecated Creatinine [Mass/volume] in Body fluid


name: Deprecated Microscopic observation [Identifier] in Tissue by Dark field examination


name: Deprecated Eastern equine encephalitis virus Ab [Titer] in Serum


name: Deprecated Eosinophils/100 leukocytes in Body fluid by Manual count


name: Deprecated Estradiol [Mass/volume] in Saliva


name: Deprecated Helicobacter pylori Ab [Titer] in Serum


name: Deprecated HIV 1 RNA [Units/volume] in Serum or Plasma by Probe with amplification


name: Deprecated HLA-B27 [Presence] in Blood from donor


name: Deprecated HLA-B35 [Presence] in Blood from donor


name: Deprecated Haemophilus influenzae C Ag [Presence] in Unspecified specimen by Immunofluorescence


name: Deprecated Herbicide [Identifier] in Unspecified specimen


name: Deprecated Insulin [Units/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO


name: Deprecated La Crosse virus IgG Ab [Titer] in Serum


name: Deprecated La Crosse virus IgM Ab [Titer] in Serum


name: Deprecated Lymphocytes/100 leukocytes in Body fluid by Manual count


name: Deprecated Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by DNA probe


name: Deprecated Nairobi sheep disease virus Ab [Titer] in Serum


name: Deprecated Neutrophils [#/volume] in Blood by Automated count


name: Deprecated Neutrophils/100 leukocytes in Body fluid by Manual count


name: Deprecated Pasteurella multocida serotype [Identifier] in Unspecified specimen by Agglutination


name: Deprecated Phosphate [Mass/volume] in Body fluid


name: Deprecated Platelets [#/volume] in Blood by Automated count


name: Deprecated Rabies virus Ag [Units/volume] in Tissue by Immunofluorescence


name: Deprecated Rabies virus Ag [Units/volume] in Unspecified specimen by Immunofluorescence


name: Deprecated Rabies virus strain identified in Tissue by Organism specific culture


name: Deprecated Rabies virus strain identified in Unspecified specimen by Organism specific culture


name: Deprecated Salmonella sp identified in Unspecified specimen by Organism specific culture


name: Deprecated Specimen source [Identifier] in Cervical or vaginal smear or scraping by Cyto stain


name: Deprecated Spermatozoa [#/volume] in Semen


name: Deprecated Spermatozoa Ab [Units/volume] in Semen


name: Deprecated Spermatozoa Motile/100 spermatozoa in Semen


name: Deprecated Taylorella equigenitalis Ag [Presence] in Unspecified specimen by Agglutination


name: Deprecated Urate [Mass/volume] in Body fluid


name: Deprecated Western equine encephalitis virus Ab [Titer] in Serum


name: Deprecated t(15,17)(PML,RARA) Translocation [Presence] in Blood or Tissue by Molecular genetics method


name: Deprecated Microscopic observation [Identifier] in Stool by Trichrome stain


name: Deprecated Microscopic observation [Identifier] in Tissue by Toluidine blue O stain


name: Deprecated Microscopic observation [Identifier] in Tissue by Warthin-Starry stain


name: Deprecated Microscopic observation [Identifier] in Tissue by Wright Giemsa stain


name: Views^W Tc-99m tagged RBC IV:Find:Pt:Abdomen>Liver:Doc:NM


name: aspirin / citric acid / sodium bicarbonate


name: Alka-Seltzer Plus Cold and Cough Reformulated Mar 2007


name: Measurement of lipoprotein-associated phospholipase A2 (Lp-PLA2)


name: Metathesaurus FDA Structured Product Labels


name: CONTACT LENS (FOR HARD LENS) SOAKING SOLUTION


name: Titanium Dioxide/Zinc Oxide 5%-7.5% Topical application Cream


name: {21 (ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Balziva 28 Day]


name: Mechlorethamine Hydrochloride Bulk powder


name: AMERIGEL Care Moisturizing Topical Lotion


name: Sunmark Bandage Fabric Knuckle Fingertip


name: Sunmark Elastic Bandage Plus Clips 3"x4.5 yar


name: Sunmark Elastic Bandage Plus Clips 4"x4.5 yar


name: Sunmark Elastic Bandage S/Adhesive 3"x1.5 yar


name: Sunmark Elastic Bandage S/Adhesive 4"x1.5 yar


name: DUO-CARE Glucose Plus Blood Pressure Monitor


name: infant formula, special metabolic, iron, methionine-free 13 gram-475 kcal/100 gram ORAL POWDER (GRAM)


name: nutritional therapy for phenylketonuria (PKU) no.8 8.33 gram-69 kcal/20 gram ORAL POWDER IN PACKET (EA)


name: nutritional therapy, metabolic disorder, methionine-free 25 gram-324 kcal/100 gram ORAL POWDER (GRAM)


name: nutritional therapy, metabolic disorder, methionine-free 40 gram-305 kcal/100 gram ORAL POWDER (GRAM)


name: calcium gluconate,calcium phosphate dibasic


name: calcium carbonate, calcium citrate, calcium glucon


name: calcium citrate,calcium gluconate,calcium lactate


name: calcium carbonate, gluconate, HVP chelate


name: colostomy bag, non-sterile 10 1/4" 470 mL MISCELL EACH


name: colostomy bag, non-sterile 11 1/4" 760 mL MISCELL EACH


name: blood-glucose meter, pre-loaded test strips


name: gum mastic/storax/methyl salicylate/alcohol MISCELL DROPPERETTE, SINGLE-USE DROP DISPENSER


name: gum mastic/storax/methyl salicylate/alcohol MISCELL LIQUID (ML)


name: gum mastic/storax/methyl salicylate/alcohol MISCELL AEROSOL, SPRAY (ML)


name: hydrocolloid dressing 6 3/4 " X 6 3/8 " TOPICAL BANDAGE


name: nut.therapy, phenylketonuria (PKU) with iron, no11


name: nut.therapy, phenylketonuria(PKU) with iron, no.12


name: nut.therapy, phenylketonuria(PKU) with iron, no.13


name: nut.therapy, phenylketonuria(PKU) with iron, no.14


name: nut.therapy, phenylketonuria(PKU) with iron, no.15


name: nut.therapy, phenylketonuria(PKU) with iron, no.17


name: nut.therapy, phenylketonuria(PKU) with iron, no.18


name: nut.therapy, phenylketonuria(PKU) with iron, no.19


name: nut.therapy, phenylketonuria (PKU) with iron, no.9


name: nutritional tx, impaired hepatic function #1


name: nutritional therapy for phenylketonuria (PKU) with iron no.7 10 gram-41 kcal/14.3 gram ORAL POWDER IN PACKET (EA)


name: nutritional therapy for phenylketonuria (PKU) with iron no.6 40 gram-305 kcal/100 gram ORAL POWDER IN PACKET (EA)


name: nutritional therapy for phenylketonuria (PKU) with iron no.6 40 gram-305 kcal/100 gram ORAL POWDER (GRAM)


name: nutritional therapy for phenylketonuria(PKU) with iron no.5 25 gram-324 kcal/100 gram ORAL POWDER (GRAM)


name: periton. dialysis soln no.28 with icodextrin 7.5 %


name: peritoneal dialysis soln 20 with dextrose 4.25 %


name: peritoneal dialysis soln no.13 with dextrose 2.5 %


name: peritoneal dialysis soln no.21 with dextrose 2.5 %


name: peritoneal dialysis soln no 27 with dextrose 3.5 %


name: peritoneal dialysis soln no.3 with dextrose 4.25 %


name: peritoneal dialysis soln no.4 with 1.5 % dextrose


name: peritoneal dialysis soln no.6 with dextrose 1.5 %


name: peritoneal dialysis soln no.7 with 2.5 % dextrose


name: peritoneal dialysis soln no.8 with dextrose 4.25 %


name: petrolatum,white/carboxymethylcellulose MISCELL OINTMENT (GRAM)


name: phenylephrine HCl/acetaminophen/doxylamine succinate 5 mg-325 mg (day)/5 mg-325 mg-6.25 mg (night) ORAL TABLET, SEQUENTIAL


name: silicone oil-rmn3 (partial fluorinated olefin) mix


name: {84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Quasense 91 Day]


name: SODIUM PERBORATE MONOHYDRATE 1.2 g in 1.7 g ORAL POWDER, FOR SOLUTION [Amosan Oral Wound Cleanser Spearmint]


name: API Healthcare Anti-Fungal Vaginal Cream


name: Canesten Clotrimazole Thrush Treatment 3 Day


name: Canesten Clotrimazole Thrush Treatment 6 Day


name: Chem Mart Clotrimazole Thrush Treatment 3 Day


name: Chem Mart Clotrimazole Thrush Treatment 6 Day


name: {180 (insulin human, rDNA origin 1 MG Inhalation Powder) / 90 (insulin human, rDNA origin 3 MG Inhalation Powder) } Pack


name: IRRIGATING SYRINGE CATHETER 60ML KENDALL #8881560141


name: {21 (prednisone 10 MG Oral Tablet) } Pack


name: {48 (prednisone 10 MG Oral Tablet) } Pack


name: {48 (prednisone 5 MG Oral Tablet) } Pack


name: Phytum Antipelliculaire Shampooing Purifiant


name: Sunmark Sunscreen Plus E and Aloe SPF 30


name: CATHERIZATION SET,INTERMITTENT 10FR BARD #4A5110


name: CATHERIZATION SET,INTERMITTENT 10FR H#96104


name: CATHERIZATION SET,INTERMITTENT 12FR BARD #4A5142


name: CATHERIZATION SET,INTERMITTENT 12FR H#96124


name: CATHERIZATION SET,INTERMITTENT 14FR BARD #4A5144


name: CATHERIZATION SET,INTERMITTENT 14FR H#96144


name: CATHERIZATION SET,INTERMITTENT 16FR H#96164


name: CATHERIZATION SET,INTERMITTENT 18FR H#96184


name: CATHERIZATION SET,INTERMITTENT 6FR H#96064


name: CATHERIZATION SET,INTERMITTENT 8FR BARD #4A5108


name: CATHERIZATION SET,INTERMITTENT 8FR H#96084


name: CATHETER,INTERMITTENT 12FR RUSCH #221800-12


name: CATHETER,INTERMITTENT 14FR RUSCH #221800-14


name: CATHETER,INTERMITTENT 16FR RUSCH #221800-16


name: CATHETER,INTERMITTENT 18FR RUSCH #221800-18


name: DRESSING,COVADERM 4IN X 10IN DEROYAL #46-004


name: DRESSING,COVADERM 4IN X 14IN DEROYAL #46-005


name: DRESSING,COVADERM 4IN X 4IN DEROYAL #46-001


name: DRESSING,COVADERM 4IN X 6IN DEROYAL #46-002


name: DRESSING,COVADERM 4IN X 8IN DEROYAL #46-003


name: DRESSING,OIL EMULSION 5IN X 9IN KEN#6116


name: DRESSING,SILVERCEL 4.25IN X 4.25IN JJ#800404


name: DRESSING,SOFSORB 3IN X 3IN DEROYAL#46-109


name: DRESSING,SOFSORB 4IN X 6IN DEROYAL#46-101


name: DRESSING,SOFSORB 4IN X 9IN DEROYAL#46-106


name: NON-ADHESIVE UROSTOMY SYSTEM LARGE #501002


name: NON-ADHESIVE UROSTOMY SYSTEM SMALL #501000


name: TAPE,MEDIPORE SOFT CLOTH 1IN X 10YD 3M #2961


name: TAPE,MEDIPORE SOFT CLOTH 2IN X 10YD 3M #2962


name: TAPE,MEDIPORE SOFT CLOTH 3IN X 10YD 3M #2963


name: TAPE,MEDIPORE SOFT CLOTH 4IN X 10YD 3M #2964


name: TAPE,MEDIPORE SOFT CLOTH 6IN X 10YD 3M #2966


name: TAPE,MEDIPORE SOFT CLOTH 8IN X 10YD 3M #2968


name: UNDERPAD,BED,WASHABLE 30IN X 34IN PRIVA #P11604


name: UNDERPAD,BED,WASHABLE 30IN X 34IN PRIVA #P7204


name: UNDERPAD,BED,WASHABLE 34IN X 36IN KENAD #61-8020/10


name: UNDERPAD,BED,WASHABLE 34IN X 36IN PRIVA #P12205


name: UNDERPAD,BED,WASHABLE 34IN X 36IN PRIVA #P12605


name: UNDERPAD,BED,WASHABLE 34IN X 36IN PRIVA #P12605H


name: UNDERPAD,BED,WASHABLE 34IN X 36IN PRIVA #P13205


name: UNDERPAD,BED,WASHABLE 34IN X 36IN PRIVA #P13605


name: UNDERPAD,BED,WASHABLE 34IN X 52IN PRIVA #P12606


name: {28 (norethindrone 0.35 MG Oral Tablet) } Pack [Nora-BE 28 Day]


name: {28 (norethindrone 0.35 MG Oral Tablet) } Pack [Ortho Micronor 28 Day]


name: {12 (ethinyl estradiol 0.035 MG / norethindrone 0.5 MG Oral Tablet) / 9 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Aranelle 28]


name: {21 (ethinyl estradiol 0.03 MG / norgestrel 0.3 MG Oral Tablet) } Pack [Lo/Ovral 21 Day]


name: {7 (desogestrel 0.1 MG / ethinyl estradiol 0.025 MG Oral Tablet) / 7 (desogestrel 0.125 MG / ethinyl estradiol 0.025 MG Oral Tablet) / 7 (desogestrel 0.15 MG / ethinyl estradiol 0.025 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Cesia 28 Day]


name: {21 (ethinyl estradiol 0.03 MG / norgestrel 0.3 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Cryselle 28]


name: {21 (desogestrel 0.15 MG / ethinyl estradiol 0.03 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack


name: {84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Jolessa 91 Day]


name: {21 (ethinyl estradiol 0.035 MG / ethynodiol diacetate 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Kelnor 1/35 28 Day]


name: {21 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Lutera 28 Day]


name: {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) } Pack [Microgestin 1/20 21 Day]


name: {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Microgestin Fe 1/20 28 Day]


name: {21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [MonoNessa 28 Day]


name: {10 (ethinyl estradiol 0.035 MG / norethindrone 0.5 MG Oral Tablet) / 11 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Necon 10/11 28 Day]


name: {7 (ethinyl estradiol 0.035 MG / norethindrone 0.5 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norethindrone 0.75 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Nortrel 7/7/7 28 Day]


name: {21 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Nortrel 1/35 28 Day]


name: {21 (ethinyl estradiol 0.05 MG / norgestrel 0.5 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Ogestrel 28 Day]


name: {21 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Portia 28 Day]


name: {21 (desogestrel 0.15 MG / ethinyl estradiol 0.03 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Reclipsen 28 Day]


name: {21 (desogestrel 0.15 MG / ethinyl estradiol 0.03 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Solia 28 Day]


name: {21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Sprintec 28 Day]


name: {7 (ethinyl estradiol 0.035 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Tri-Previfem 28 Day]


name: {24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG Oral Tablet) / 4 (inert ingredients 1 MG Oral Tablet) } Pack [Yaz 28 Day]


name: {6 (0.2 ML interferon beta-1a 0.044 MG/ML Prefilled Syringe [Rebif]) / 6 (0.5 ML interferon beta-1a 0.044 MG/ML Prefilled Syringe [Rebif]) } Pack [Rebif Titration]


name: UNDERPAD,BED 23IN X 36IN REASSURE PREMIUM


name: UNDERPAD,BED 30IN X 36IN REASSURE PREMIUM


name: DEXTRANOMER MICROSPHERES (DEFLUX) 50MG/ML SYR,1ML


name: Sidekick Blood Glucose Testing Plus Free Mete


name: dexbrompheniramine / hydrocodone / phenylephrine


name: hydroquinone/avobenzone/octinoxate/octocrylene 4 % TOPICAL EMULSION (GRAM)


name: leucine 0.1 gram-15 kcal/4 gram ORAL POWDER IN PACKET (EA)


name: calcium citrate,calcium lactate,calcium phosphate


name: hydrocolloid dressing 2" X 8" TOPICAL BANDAGE


name: hydrocolloid dressing 5 1/8" X 6" TOPICAL BANDAGE


name: hydrocolloid dressing 6 3/4" X 8" TOPICAL BANDAGE


name: iopanoic acid 100 % MISCELL POWDER (GRAM)


name: medroxyprogesterone acetate, micronized 100 % MISCELL POWDER (GRAM)


name: peritoneal dialysis soln no.19 and dextrose 1.5 %


name: regulation of multicellular organismal process


name: general adaptation syndrome, behavioral process


name: regulation of sensory perception of pain


name: regulation of nervous system development


name: repression of premature neural plate formation


name: somatic diversification of immune receptors


name: somatic diversification of DSCAM-based immune receptors


name: somatic diversification of variable lymphocyte receptors of jawless fish


name: innate immune response activating cell surface receptor signaling pathway


name: pattern recognition receptor signaling pathway


name: stimulatory killer cell immunoglobulin-like receptor signaling pathway


name: detection of endoplasmic reticulum overloading


name: imaginal disc-derived genitalia development


name: imaginal disc-derived male genitalia development


name: imaginal disc-derived female genitalia development


name: myo-inositol hexakisphosphate biosynthetic process


name: regulation of tissue kallikrein-kinin cascade


name: somatic diversification of immunoglobulins


name: antigen sampling in mucosal-associated lymphoid tissue


name: antigen transport in mucosal-associated lymphoid tissue


name: antigen sampling by dendritic cells in mucosal-associated lymphoid tissue


name: antigen sampling by M cells in mucosal-associated lymphoid tissue


name: immunoglobulin production in mucosal tissue


name: immune response-activating cell surface receptor signaling pathway


name: Fc receptor mediated stimulatory signaling pathway


name: immune complex clearance by erythrocytes


name: immune complex clearance by monocytes and macrophages


name: production of molecular mediator of immune response


name: production of cellular mediator of immune response


name: regulation of plasma kallikrein-kinin cascade


name: smoothened signaling pathway involved in ventral spinal cord interneuron specification


name: smoothened signaling pathway involved in spinal cord motor neuron cell fate specification


name: Wnt signaling pathway involved in forebrain neuroblast division


name: fibroblast growth factor receptor signaling pathway involved in forebrain neuron fate commitment


name: smoothened signaling pathway involved in ventral spinal cord patterning


name: regulation of cell proliferation in dorsal spinal cord


name: regulation of cerebellar granule cell precursor proliferation


name: negative regulation of anterior neural cell fate commitment of the neural plate by fibroblast growth factor receptor signaling pathway


name: regulation of anatomical structure morphogenesis


name: multicellular organism adhesion to substrate


name: somatic diversification of immune receptors via somatic mutation


name: somatic diversification of FREP-based immune receptors


name: somatic diversification of T cell receptor genes


name: somatic diversification of immune receptors by N region addition


name: somatic diversification of immunoglobulin genes by N region addition


name: somatic diversification of T cell receptor genes by N region addition


name: regulation of antigen processing and presentation


name: regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II


name: regulation of antigen processing and presentation of peptide antigen


name: regulation of antigen processing and presentation of peptide antigen via MHC class II


name: regulation of antigen processing and presentation of peptide antigen via MHC class I


name: regulation of antigen processing and presentation via MHC class Ib


name: regulation of antigen processing and presentation of peptide antigen via MHC class Ib


name: regulation of antigen processing and presentation of lipid antigen via MHC class Ib


name: regulation of antigen processing and presentation of polysaccharide antigen via MHC class II


name: regulation of proteolysis associated with antigen processing and presentation


name: regulation of central tolerance induction


name: regulation of peripheral tolerance induction


name: regulation of B cell tolerance induction


name: regulation of production of molecular mediator of immune response


name: regulation of leukocyte mediated immunity


name: regulation of lymphocyte mediated immunity


name: regulation of monoatomic ion transmembrane transporter activity


name: negative regulation of ion transmembrane transporter activity


name: active evasion of host immune response via regulation of host complement system


name: regulation of natural killer cell mediated immunity


name: cell surface pattern recognition receptor signaling pathway


name: MyD88-dependent toll-like receptor signaling pathway


name: MyD88-independent toll-like receptor signaling pathway


name: immune response-activating signaling pathway


name: regulation of antimicrobial humoral response


name: immune response-inhibiting signal transduction


name: innate immune response-inhibiting signal transduction


name: immune response-inhibiting cell surface receptor signaling pathway


name: Fc receptor mediated inhibitory signaling pathway


name: regulation of antimicrobial peptide production


name: regulation of antibacterial peptide production


name: regulation of antifungal peptide production


name: regulation of antimicrobial peptide biosynthetic process


name: regulation of antibacterial peptide biosynthetic process


name: regulation of antifungal peptide biosynthetic process


name: regulation of myeloid leukocyte mediated immunity


name: regulation of axon extension involved in regeneration


name: leukemia inhibitory factor signaling pathway


name: homeostasis of number of cells in a free-living population


name: Seeks information about methods to prevent complications


name: Uses correct procedure for insulin administration


name: Reports non-healing breaks in skin to primary care provider


name: Participates in prescribed educational program


name: Performs correct procedure for blood glucose testing


name: Obtains health care if blood glucose levels fluctuate outside of recommendations


name: Monitors frequency of hypoglycemia episodes


name: Participates in smoking cessation regimen


name: Monitors prescribed medication therapeutic effects


name: Uses effective weight control strategies


name: Uses preventive measures to reduce risk for complications


name: Obtains dilated vision examination as recommended


name: Participates in decisions related to care


name: Participates in decisions about resuscitation status


name: Participates in decisions about hospitalization


name: Performs activities of daily living (ADLs) independently


name: Expresses feelings and emotions openly among members


name: Establishes schedule for family routines and activities


name: Uses family-centered stress reduction strategies


name: Involves family members in decision-making


name: Creates environment where members can openly express feelings


name: Allocates responsibilities among members


name: Obtains adequate resources to meet needs of members


name: Members participate in community activities


name: Appropriate dependent adult care provisions


name: Members share thoughts, feelings, interests, concerns


name: Members communicate openly and honestly with one another


name: Members provide support during times of crisis


name: Members assist one another in performing roles and daily tasks


name: Members express affection to one another


name: Provides activities appropriate to age and ability for affected member


name: Meets psychosocial needs of family members


name: Adapts family routine to accommodate needs of affected member


name: Meets developmental needs of family members


name: Structures environment to avoid embarrassment of affected member


name: Structures activities to avoid embarrassment of affected member


name: Participates in mutual goal setting for care


name: Makes decisions when patient is unable to do so


name: Defines needs and problems relevant to care


name: Proposes practical, constructive solutions for disputes


name: Uses health care team for information and assistance


name: Accepts assistance with instrumental activities of daily living from friends


name: Effective use of conflict management strategies


name: Expresses confidence in overcoming adversities


name: Uses community groups for emotional support


name: Accepts assistance with direct care from extended family


name: Accepts assistance with direct care from friends


name: Supports individuality and independence among members


name: Accepts assistance with instrumental activities of daily living from extended family


name: Seeks emotional support from extended family


name: Adjusts schedules to support and assist members


name: Works cooperatively to meet family goals


name: Encourages individual autonomy and independence


name: Members verbalize meaning of health crisis


name: Members provide comforting touch to ill member


name: Provides accurate information to other members


name: Contacts other members as desired by ill member


name: Members express desire to support ill member


name: Requests information about patient condition


name: Collaborates with health provider in determining care


name: Members maintain communication with ill member


name: Collaborates with ill member in determining care


name: Members express feelings and emotions of concern for ill member


name: Monitors length of time between episodes


name: Deceleration patterns in electronic fetal monitor findings


name: Perception of the importance of incorporating health behaviors with cultural beliefs


name: Uses support services for hearing impaired


name: Cares for internal hearing assistive devices correctly


name: Cares for external hearing assistive devices correctly


name: Uses closed captioning for television viewing


name: Reminds others to use techniques that advantage hearing


name: Monitors symptoms of hearing deterioration


name: Difficulty with tasks that require sustained cognitive effort


name: Intrusive, abrasive, loud, interpersonal interactions


name: Blurts out answers before the question is completed


name: Alterations in differential white blood count


name: Level of auto-antibodies or auto-antigens


name: Metacarpophalangeal flexion 90 degrees (R)


name: Metacarpophalangeal flexion 90 degrees (L)


name: Proximal interphalangeal flexion 100-120 degrees (R)


name: Proximal interphalangeal extension 0 degrees (R)


name: Metacarpophalangeal extension 0 degrees (R)


name: Metacarpophalangeal hyperflexion 30 degrees (L)


name: Metacarpophalangeal hyperflexion 30 degrees (R)


name: Distal interphalangeal extension 0 degrees (L)


name: Proximal interphalangeal flexion 100-120 degrees (L)


name: Distal interphalangeal extension 0 degrees (R)


name: Metacarpophalangeal extension 0 degrees (L)


name: Distal interphalangeal flexion 45-80 degrees (L)


name: Distal interphalangeal flexion 45-80 degrees (R)


name: Proximal interphalangeal extension 0 degrees (L)


name: Hyperextension knee straight 15 degrees (R)


name: Hyperextension knee straight 15 degrees (L)


name: Positional causes of muscle or joint pain from sitting


name: Positional causes of muscle or joint pain from lifting


name: Positional causes of muscle or joint pain from lying


name: Exercises to strengthen lower abdominal muscles


name: Relationship between breastfeeding and infant immunity


name: Reasons for avoidance of water and supplements for infant


name: Importance of completing cardiac rehabilitation


name: Cultural influences on compliance to treatment regimen


name: Importance of family learning cardiopulmonary resuscitation


name: Benefits of following a low-fat, low-cholesterol diet


name: Care options for assistance with medical emergencies


name: Strategies to prevent motor vehicle accidents


name: Age-appropriate cardiopulmonary resuscitation techniques


name: Effectiveness of chosen contraceptive method


name: Effects of chosen contraceptive on sexually transmitted disease transmission


name: Influence of personal values on chosen contraceptive method


name: Correct use of chosen contraceptive method


name: Onset, peak, and duration of prescribed insulin


name: Actions to take in response to blood glucose levels


name: Impact of acute illness on blood glucose level


name: Correct procedure for urine ketone testing


name: Importance of dilated eye exam and vision testing by an ophthalmologist


name: Procedures to be followed in treating hyperglycemia


name: Procedures to be followed in treating hypoglycemia


name: Importance of maintaining blood glucose level within target range


name: Proper technique to draw up and administer insulin


name: Role of exercise in blood glucose control


name: Interpretation of nutritional information on food labels


name: Relationship among diet, exercise, and weight


name: Blood pressure changes that increase risk for falls


name: Acute illnesses that increase risk for falls


name: Non-prescription medication that increase risk for falls


name: Prescribed medication that increase risk for falls


name: Chronic conditions that increase risk for falls


name: Influence of vaginal/uterine environment


name: Use of basal body temperature to predict ovulation


name: Considerations when choosing a childcare provider


name: Strategies to adjust to addition of infant


name: Precautions when pets are in the household


name: Normal physical sensations following delivery


name: Time frame for resumption of sexual activity


name: Environmental hazards at work that affect fetal development


name: Factors to consider when deciding to become a parent


name: Environmental hazards at home that affect fetal development


name: Appropriate self-care for discomforts of pregnancy


name: Psychological changes associated with pregnancy


name: Correct use of motor vehicle safety devices


name: Warning signs of pregnancy complications


name: Societal influences on personal sexual behavior


name: Strategies to prevent sexually transmitted diseases


name: Participates in low physical demand leisure activities


name: Participates in high physical demand leisure activities


name: Sense of loss due to separation from another


name: PaO2 (partial pressure of oxygen in arterial blood)


name: FiO2 (fraction of inspired oxygen) meets oxygen demand


name: Mechanical Ventilation Weaning Response: Adult


name: Welcomes opportunity to make contributions


name: Expresses that performance will lead to desired outcome


name: Expresses belief in ability to perform action


name: Uses antiemetic medication as recommended


name: Reports bothersome side effects from antiemetics


name: Reports uncontrolled symptoms to health professional


name: Treatment delays due to symptom severity


name: Interference with activities of daily living (ADLs)


name: Withdrawal from interpersonal relationships


name: Monitors amount and consistency of stool


name: Follows schedule for changing ostomy bag


name: Monitors for complications related to stoma


name: Annoyance with disruptive effects of pain


name: Reports changes in pain symptoms to health professional


name: Disruption of interpersonal relationships


name: Uses strategies to prevent firearm injuries


name: Uses strategies to encourage use of protective gear during high-risk activities


name: Uses strategies to prevent participation in violence


name: Uses strategies to encourage seat belt use


name: Uses strategies to prevent recreational drug use


name: Monitors use of sport and recreational equipment


name: Uses strategies to prevent high-risk sexual activity


name: Uses strategies to encourage safe driving


name: Uses strategies to protect from sun exposure


name: Uses strategies to prevent water accidents


name: Uses strategies to prevent exposure to toxic chemicals


name: Uses strategies to prevent medication misuse


name: Uses strategies to prevent exposure to excessive noise


name: Uses strategies to prevent precocious sexual behavior


name: Selects appropriate clothing for activity


name: Provides supervision while on playground equipment


name: Supervises selection of weather-appropriate clothing


name: Avoids leaving child in motor vehicle unsupervised


name: Locks or removes doors from unused appliances


name: Uses strategies to encourage use of protective helmet


name: Ensures home playground equipment meets safety guidelines


name: Provides supervision around pets and animals


name: Monitors proper use of car seat/seat belt


name: Maintains environment to prevent poisoning


name: Maintains environment to prevent harmful falls


name: Maintains environment to prevent suffocation


name: Provides constant supervision around pets and animals


name: Provides constant supervision around water


name: Provides appropriate supervision for child


name: Imparts values that promote functioning in society


name: Considers other opinions when making choices


name: Expresses independence with decision-making process


name: Expresses satisfaction with life choices


name: Performance of instrumental activities of daily living


name: Performance of activities of daily living


name: Avoids operating motor vehicle when using alcohol


name: Expresses satisfaction with play activities


name: Post Anesthetic Recovery score (observable entity)


name: Consults health professional about non-prescription medication use


name: Uses motor vehicle safety devices correctly


name: Maintains adequate nutrient intake for pregnancy


name: Recognizes changes in general health status


name: Modifies environment to eliminate exposure to carcinogens


name: Seeks current information about cancer prevention


name: Performs recommended self-screening for cancer detection


name: Follows non-prescription medication precautions


name: Acknowledges personal risk for cardiovascular disease


name: Participates in screening for cholesterol


name: Seeks information about methods to maintain cardiovascular health


name: Evidence that emotional abuse has ceased


name: Evidence that financial exploitation has ceased


name: Relinquishes previous concept of personal health


name: Reports sense of life being worth living


name: Reports decreased need to verbalize feelings about health


name: Ease of performing activities of daily living


name: Ability to speak during physical activity


name: Modifies career goals to accommodate disability


name: Uses strategies to reduce stress related to disability


name: Modifies lifestyle to accommodate disability


name: Identifies plan to meet instrumental activities of daily living


name: Identifies plan to meet activities of daily living


name: Verbalizes ability to adjust to disability


name: Identifies ways to increase sense of control


name: Identifies risk of complications associated with disability


name: Identifies ways to cope with life changes


name: Reports decrease in stress related to disability


name: Uses physical activity to reduce pent-up energy


name: Acknowledges consequences associated with unintended pregnancy


name: Uses adequate lighting for activity being performed


name: Monitors symptoms of vision deterioration


name: Takes breaks from activity causing eye strain


name: Obtains information about changes in health recommendations


name: Contacts health professional when medication side effects occur


name: Implements safety practices in environment


name: Maintains positive attitude toward seizure disorder


name: Administers topical medication correctly


name: Responds to full bladder in timely manner


name: Instructs others in appropriate health maintenance activities


name: Takes corrective action when care is not appropriate


name: Instructs others in appropriate care behaviors


name: Determines that care is completed appropriately


name: Hears a whisper 6 inches from left ear (voice test)


name: Auditory discrimination of discrete sounds


name: Hears a whisper 6 inches from right ear (voice test)


name: Loss of ability to distinguish conversation from background environmental noise


name: Monitors behavioral manifestations of anxiety


name: Monitors physical manifestations of anxiety


name: Positions self upright for eating and drinking


name: Initiates action to manage personal triggers


name: Sleeps through the night with no cough or wheeze


name: Initiates action to avoid personal triggers


name: Participates in age-appropriate activities


name: Makes appropriate environmental modifications


name: Prothrombin time - international normalized ratio (PT-INR)


name: Adjustment to body changes due to surgery


name: Adjustment to body changes due to injury


name: Ossification, consolidation, and remodeling


name: Gets to toilet between urge and evacuation of stool


name: Describes relationship of food intake to stool consistency


name: Follows recommendations for sexual activity


name: Reports signs and symptoms of depression


name: Uses only non-prescription medication approved by health professional


name: Participates in prescribed cardiac rehabilitation


name: Reports decreased need to verbalize feelings about change


name: Assists with care recipient's instrumental activities of daily living needs


name: Expresses knowledge of partner's sexual needs


name: Expresses knowledge of personal sexual capabilities


name: Communicates sexual preferences with partner


name: Performs sexually if environment conducive


name: Expresses knowledge of personal sexual needs


name: Expresses knowledge of partner's sexual capabilities


name: Sustains penile/clitoral erection through orgasm


name: Expresses comfort with sexual expression


name: Performs sexually without coercion of partner


name: Refrains from substance use that adversely affects sexual function


name: Exhibits clear sense of sexual orientation


name: Integrates sexual orientation into life roles


name: Describes risks associated with sexual activity


name: Exhibits comfort with sexual orientation


name: Challenges negative images of sexual self


name: Uses healthy coping behaviors to resolve sexual identity issues


name: Uses precautions to minimize risks associated with sexual activity


name: Increased muscle tension in neck, shoulders, and back


name: Standardized test performance at grade level or higher


name: Reports to the health office for medications at appropriate time


name: Participation in extracurricular school activities


name: Progression to graduation on expected schedule


name: Return to class after visit to health office


name: Occurrence of sexually transmitted disease


name: Participation in curricular school activities


name: Academic performance at grade level or higher


name: Uses available mental health care services


name: Reports adequate pain control for chronic pain


name: Meal duration with respect to amount consumed


name: Number of swallows appropriate for bolus size/texture


name: Maintains neutral head and trunk position


name: Delivery of bolus to hypopharynx is timed with swallow reflex


name: Maintains neutral head and neck position


name: Delivery of bolus to hypopharynx timed with swallow reflex


name: Family sharing of responsibilities for caregiving


name: Support for instrumental activities of daily living


name: Holds head in horizontal line with back when prone


name: PaCO2 (partial pressure of carbon dioxide in arterial blood)


name: partial pressure of oxygen in arterial blood


name: Assistance with access to health providers


name: Availability of supplies needed for care


name: Availability of equipment needed for care


name: Access to registered nurse responsible for care


name: Informed of registered nurse and assistive staff responsible for care


name: Avoidance of unnecessary treatments and procedures


name: Information provided about options of care


name: Orientation to room, equipment, and routines


name: Alternative communication methods used as needed


name: Discrepancies in information are resolved in a timely manner


name: Questions answered in a reasonable length of time


name: Discussion of strategies for returning to homemaking activities


name: Client satisfaction - coordination of care


name: Client resources identified in discharge planning


name: Discussion of strategies to meet household needs


name: Personal preparation to deal with potential health problems


name: Opportunity provided to express concerns about managing self-care


name: Personal preferences included in care plan


name: Opportunity to demonstrate care activities


name: Information provided about what to expect when transferred


name: Discussion of strategies for returning to community activities


name: Discussion of guidelines for returning to sexual activities


name: Discussion of strategies to meet care needs


name: Information provided to manage self-care


name: Assistance with managing relocation costs and finances


name: Discussion of strategies for returning to work


name: Incorporation of cultural beliefs in health teaching


name: Respect for family members' participation in care


name: Included in planning for optimal mobility and self-care


name: Opportunity to do self-care unless assistance requested


name: Exercise routine provided to gain or maintain flexibility


name: Room space provided for equipment needed to support functional independence


name: Included in planning time schedule for self-care


name: Information provided to manage medication


name: Exercise routine provided to gain or maintain mobility


name: Assistance with selecting food and fluid


name: Availability of chairs for family and visitors


name: Orientation of family and visitors to facilities


name: Availability of space nearby for family and visitors


name: Information provided about advance directives


name: Personal preferences for care considered


name: Care consistent with religious and spiritual needs


name: Information provided about available services of other disciplines


name: Confidentiality of client information maintained


name: Information provided about support groups


name: Avoidance of repetitive questions by more than one provider


name: Identifies medication that interferes with urinary control


name: Gets to toilet between urge and passage of urine


name: Maintains predictable pattern of voiding


name: Urine leakage with sneezing, laughing, or lifting


name: Reminds others to use techniques that advantage vision


name: Recognizes signs and symptoms of electrolyte imbalance


name: Perceived inadequacy in interpersonal relationships


name: Support for identifying ways to cope with stress


name: Support for adjusting to functional changes


name: Assistance with identifying community support groups for family


name: Information provided about expected improvement


name: Assistance with identifying community support groups for client


name: Counseling provided to improve emotional stability


name: Support for working through feelings of loss


name: Counseling provided to improve social interactions


name: Information provided about course of illness


name: Counseling provided to improve mental functioning


name: Discussion of strategies to cope with mental impairments


name: Support for finding own solutions to problems


name: Information provided about treatment risks and complications


name: Explanation of safety rules and procedures


name: Maintenance of safe environment when cognitive function is impaired


name: Client identified before receiving medication


name: Maintenance of protective environment when at risk for self-injury


name: Warning signs of high-risk environment clearly displayed


name: Referrals made to other health providers


name: Explanation of medication therapeutic effects


name: Quality of instructional material provided


name: Information provided about signs of complications


name: Explanation of self-care responsibilities for medication management


name: Personal knowledge considered before teaching


name: Explanation of self-care responsibilities for treatment


name: Explanation of results of diagnostic tests


name: Discussion of strategies to improve health


name: Explanations provided in understandable terms


name: Explanation of available health resources


name: Explanation of diagnostic tests and preparation


name: Registered nurse knowledge of health history


name: Registered nurse knowledge of medication


name: Registered nurse knowledge of disease process


name: Room temperature (comfort level finding)


name: Participation rates in community activities


name: Representation of all segments of the community in problem-solving


name: Consideration of common and competing interests among groups when solving problems


name: Participation rate in local government elections


name: Focus on community versus individual agendas


name: Flexibility of structures and processes that guide community decision-making


name: Community issues articulated in community forums


name: Notification network to alert response personnel


name: Public health disease surveillance system


name: Plan to protect health and safety of response personnel


name: Ongoing training for disaster response personnel


name: Essential agency involvement in planning


name: Policy designating temporary administrative authority


name: Media plan for public information updates


name: Public education on disaster warning and response


name: Assignment of agency responsibilities in the event of disaster


name: Operational alternative utility resources


name: Notification network to alert government and support agencies


name: Regular mass casualty drills with evaluation


name: Members with adequate health insurance coverage


name: Health surveillance data systems in place


name: Participation rates in worksite health programs


name: Prevalence of health protection programs


name: Compliance with environmental health standards


name: Community health standards for health measurement and evaluation are defined


name: Community demographics represented in health care planning and evaluation


name: Participation rates in preventive health care services


name: Participation rates in school health programs


name: Monitoring of community health standards for health measurement and evaluation


name: Attendance at programs for healthy pregnancy


name: Participation rates in community health programs


name: Incidence of vaccine preventable disease at or below recommended national rate


name: Prevalence of vaccine preventable disease at or below recommended national rate


name: Immunization rates equal to or greater than current national standards


name: Screening of at-risk populations for infections


name: Availability of health care services to treat chronic disease


name: Proportion of target population participation rates in chronic disease self-management education programs


name: Prevalence of chronic disease at or below state or national rates


name: Incidence of chronic disease at or below state or national rates


name: Target population participation rates in preventive screening programs


name: Availability of chronic disease self-management education programs


name: Procurement and allocation of funding for chronic disease prevention programs


name: Compliance with national standards for chronic disease prevention and management


name: Target population participation rates in risk reduction programs


name: Provision of public education programs on chronic disease


name: Availability of preventive screening programs


name: Availability of treatment services for infected individuals


name: Availability of chemoprophylaxis for travelers


name: Availability of health care services to treat communicable diseases


name: Disease occurrences reported as mandated


name: Culturally appropriate public education about transmission of infectious disease


name: Provision of products to decrease disease spread


name: Enforcement of domestic animal vaccination


name: Water testing consistent with local, state, and federal regulations


name: Investigation and notification of contacts concerning risk for infectious disease


name: Policies supporting control of infectious disease


name: Surveillance for infectious disease outbreaks including a system of data collection, reporting, and follow-up


name: Enforcement of environmental monitoring policies


name: Enforcement of infection surveillance programs


name: Screening of all targeted high-risk groups


name: Established polices and surveillance for assuring safe food storage, handling, and preparation


name: Advocacy on behalf of renters of pre-1950 homes


name: Organization of referral and treatment services for exposed individuals


name: Referral of exposed individuals to treatment


name: Policies that require the removal of lead-based paint from all buildings


name: Use of lead screening programs by targeted high-risk groups


name: Programs to identify nutritional deficiencies in targeted high-risk groups


name: Organization of lead screening programs that includes focus on preschools


name: Abatement of known lead sources in the community


name: Incidence of elevated lead levels at or below recommended national standards


name: Programs to correct nutritional deficiencies in targeted high-risk groups


name: Participation rates of high-risk groups in education programs


name: Treatment of individuals with exposure to lead


name: Problem assessment by community stakeholders and policy makers


name: Intervention programs for high-risk groups


name: Educational programs on violence prevention


name: Enforcement of laws against hate crimes by community leaders


name: Competence in recognizing violence by community leaders


name: Competence in managing violence by community leaders


name: Systematic monitoring of community violence levels


name: Strategies to reduce violent content in the media


name: Discusses prescribed treatment regimen with health professional


name: Reports changes in symptoms to health professional


name: Monitors physical manifestations of depression


name: Monitors behavioral manifestations of depression


name: Plans strategies to reduce effects of precursors


name: Deep sleep (infant growth and development finding)


name: Development of home medication compliance regimen


name: Erosion of esophageal tumor into trachea


name: Paraprofessional/aide care case management


name: Difficulty following postpartum exercise routine


name: Noncompliance with infection control regimen


name: Speech and language therapy education, guidance, and counseling


name: Pediatric rehabilitation admission assessment


name: Obstructed means of residential entrance


name: Anatomic location of malignant melanoma with uninvolved deep margin in excised skin specimen


name: Fear of reaction regarding family planning choices


name: Surgical proximal margin involved by adenoma with low-grade dysplasia


name: Cultural barrier impedes ability to use community resources


name: Genetics education, guidance, counseling


name: Medication prescription education, guidance and counseling


name: Specimen from appendix and colon obtained by appendectomy and right colectomy


name: Finding related to ability to dispose of household sewage


name: Inconsistent use of contraception methods


name: Dissatisfaction with parenting responsibilities


name: Substance induction of cytochrome p450 CYP1A2 enzyme


name: Inadequate maintenance of developmental tasks


name: Educational barrier impedes ability to use community resources


name: Reason for unscheduled ambulance service


name: History and physical examination for surgical clearance


name: Unable to use communication device to communicate with community resources


name: Margin reflex distance (observable entity)


name: Interpreter/translator services case management


name: Caregiver difficulty providing emotional nurturance


name: Presence of neoplasm at proximal surgical margin of colectomy specimen


name: Environment contains radiological material hazards


name: Adult activity of daily living needs assessment


name: Maintenance of intraaortic balloon pump parameters


name: Continuous passive motion device monitoring


name: Difficulty with caretaking responsibilities


name: Substance use cessation education, guidance, and counseling


name: Language barrier impedes ability to use community resources


name: At increased risk for impaired liver function


name: Conversion of intravenous infusion to saline lock


name: Housing contains structural barriers to movement


name: Unable to coordinate multiple treatment plans


name: Provision of interpreter/translator services


name: Able to sit with support, unable to sit unsupported


name: Abusive emotional relationship with partner


name: Cardiovascular stress test using the adenosine stress test protocol


name: Abnormal height in relation to growth / age standard


name: Substance inhibition of cytochrome p450 CYP3A enzyme


name: Activity of daily living needs assessment


name: Drug inhibition of cytochrome p450 CYP3A enzyme


name: Renewal of prescription for diaphragm contraceptive


name: Pediatric continuous physical assessment


name: Difficulty coping with postpartum changes


name: Demonstrates adequate pain control without oral analgesics


name: Adult rehabilitation continuous assessment


name: Drug inhibition of cytochrome p450 CYP2C9 enzyme


name: Caregiver difficulty interpreting verbal communication


name: Location of malignant melanoma in specimen with involved deep margin


name: Characteristics of animals in environment


name: Drug induction of cytochrome p450 CYP1A2 enzyme


name: Drug inhibition of cytochrome p450 CYP1A2 enzyme


name: Surgical proximal margin involved by adenoma with high-grade dysplasia


name: Caregiver difficulty interpreting non-verbal communication


name: Delayed healthcare provision resulting in neglect


name: Drug induction of cytochrome p450 CYP3A enzyme


name: Recreational therapy care case management


name: Deficient knowledge of family planning methods


name: Speech and language therapy case management


name: Artificial insemination with wrong donor spermatozoa or donor egg


name: Difficulty performing laundry activities


name: Deficient knowledge of preconception health practices


name: Does not follow recommended medication dosage


name: Ammonia measurement following N-carbamoyl-L-glutamic acid loading test


name: Cocaine- and morphine-containing product


name: Lack of alternative communication skill: gestures


name: Insertion of peripherally inserted central catheter


name: Caregiver difficulty providing physical care


name: Presence of neoplasm at proximal surgical margin in appendectomy specimen


name: At increased risk for compromised human dignity


name: Antenatal ultrasound scan normal and possibly inconsistent with estimated date of delivery


name: Recreational therapy education, guidance, and counseling


name: Occupational therapy education, guidance, counseling


name: Anger management education, guidance, and counseling


name: Community outreach worker services education, guidance, and counseling


name: Limited access to community support services


name: Difficulty hearing high frequency sounds


name: Able to spontaneously say one or two words


name: Post-infective arthritis of joint of hand


name: Caregiver difficulty providing healthcare


name: Community outreach worker services surveillance


name: At increased risk for environmental contamination


name: Removal of peripherally inserted central catheter


name: Demonstrates adequate pain control with oral analgesics


name: Drug induction of cytochrome p450 CYP2C9 enzyme


name: Newborn activity of daily living needs assessment


name: Cardiovascular stress test using the dipyridamole stress test protocol


name: Abnormal head circumference in relation to growth / age standard


name: Environment contains contaminating agent


name: Knowledge level: preconception health practices


name: Difficulty understanding community service provider role


name: Does not follow recommended medication schedule


name: Personal hygiene education, guidance, and counseling


name: Change of oral contraceptive prescription


name: Transportation barrier impedes ability to use community resources


name: Able to spontaneously say three or more words


name: Dissatisfaction with community resource services


name: Inadequate achievement of developmental tasks


name: Substance induction of cytochrome p450 enzyme


name: Insufficient rest/sleep for physical condition


name: Difficulty problem solving without conflict


name: Stage of retinopathy in retinopathy of prematurity


name: Caregiver difficulty providing cognitive learning experiences


name: Drug inhibition of cytochrome p450 CYP2C19 enzyme


name: Difficulty following prenatal exercise routine


name: Difficulty performing normal routines due to substance use


name: Cardiovascular stress test using pharmacologic stress agent


name: Dissatisfaction with contraception method


name: Community resources education, guidance and counseling


name: Does not seek care for symptoms needing treatment


name: Public health investigation of communicable disease outbreak


name: Location of malignant melanoma in specimen with uninvolved lateral margin


name: Insufficient means of residential entrance


name: Maintenance of temporary epicardial cardiac pacemaker system


name: bismuth biskalcitrate / metronidazole / tetracycline


name: Drug induction of cytochrome p450 CYP2C19 enzyme


name: Caregiver difficulty providing physical safety


name: Location of melanoma in situ in specimen with uninvolved lateral margin


name: Erosion of esophageal tumor into bronchus


name: Substance induction of cytochrome p450 CYP2E1 enzyme


name: Conflicting stages of grief among family members


name: Adult rehabilitation admission assessment


name: Radial location of melanoma in situ in peripheral surgical margin of excised skin specimen


name: Community outreach worker service case management


name: Combined deep and superficial cervical plexus block


name: Environment contains uncontrolled animal


name: Difficulty hearing speech in large group setting


name: Body position for blood pressure measurement


name: Maintenance of temporary cardiac pacemaker settings


name: Responds to command of no, by briefly stopping activity


name: Unable to communicate concern to community service provider


name: Does not refill medications appropriately


name: Speech and language therapy surveillance


name: Drug inhibition of cytochrome p450 CYP2D6 enzyme


name: Signet-ring cells present, comprising less than 50 percent of malignant cells


name: Dietary management education, guidance, and counseling


name: Pediatric rehabilitation continuous assessment


name: Interpreter/translator services education, guidance, counseling


name: Maintenance of percutaneous endoscopic gastrostomy tube


name: Medication coordination/ordering education, guidance, counseling


name: Substance inhibition of cytochrome p450 enzyme


name: Inadequate use of communication device to communicate with community resources


name: Route of medication administration education


name: Dissatisfaction with caretaking responsibilities


name: At increased risk for unstable blood glucose level


name: Dual pressure spontaneous ventilation support weaning protocol


name: Infection precautions education, guidance, counseling


name: Continuity of care education, guidance, and counseling


name: Stated pain intensity within acceptable range


name: Chronic illness perception assessment scale


name: Paraprofessional/aide care education, guidance, counseling


name: Physical therapy education, guidance and counseling


name: Inadequate community resources to encourage healthy living


name: Does not seek care for symptoms needing evaluation


name: Unable to coordinate multiple appointments


name: End of life education, guidance and counseling


name: Cardiovascular stress test using the dobutamine stress test protocol


name: Respiratory therapy education, guidance, and counseling


name: Nursing care education, guidance, counseling


name: Finding related to ability to dispose food hygienically


name: Difficulty with parenting responsibilities


name: Maintenance of permanent cardiac pacemaker settings


name: Substance induction of cytochrome p450 CYP3A enzyme


name: Advance diet as tolerated (regime/therapy)


name: Radial location of malignant melanoma in peripheral surgical margin of excised specimen of skin


name: Appendix with tumor involvement, with perforation not at tumor


name: Specimen from appendix and right colon obtained by appendectomy and right hemicolectomy


name: Maintenance of temporary epicardial cardiac pacemaker settings


name: Corneal endothelial graft in place (finding)


name: Pediatric activity of daily living needs assessment


name: Maintenance of temporary cardiac pacemaker system


name: Reflex disturbances due to substance use


name: Reduced flow of (CSF) cerebrospinal fluid


name: Trial for daily interruption of sedation during mechanically assisted ventilation


name: Removal of peripheral intravenous catheter


name: albuterol, beclomethasone drug combinations


name: Mucinous adenocarcinoma cells present, comprising less than 50 percent of malignant cells


name: Instillation of dilating eye drops to eye


name: DRESSING,OPSITE IV3000 FRAME 2 3/8IN X 2 3/4IN SN#59410082


name: {28 (ethinyl estradiol 0.0025 MG / norethindrone acetate 0.5 MG Oral Tablet) } Pack [Femhrt 0.5/2.5 28 Day]


name: IRRIGATING SYRINGE,PISTON CATHETER TIP 60ML


name: {15 (estradiol 1 MG / norgestimate 0.09 MG Oral Tablet) / 15 (estradiol 1 MG Oral Tablet) } Pack [Prefest 30 Day]


name: blood sugar diagnostic, disc-type MISCELL STRIP


name: calcium amino acid chelate, calcium citrate


name: potassium hydroxide 20 % MISCELL SOLUTION, NON-ORAL


name: Syagrus romanzoffianum Ab.IgE.RAST class


name: 1.5 hours post dose luteinizing releasing hormone IV


name: 15 minutes post dose growth hormone releasing factor


name: 15 minutes post dose luteinizing releasing hormone IV


name: 15 minutes pre dose luteinizing releasing hormone IV


name: 1 hour post dose growth hormone releasing factor


name: 1 hour post dose luteinizing releasing hormone IV


name: 2.5 hours post 100 ug luteinizing releasing hormone IV


name: 2.5 hours post dose propranolol+glucagon


name: 2 hours post dose growth hormone releasing factor


name: 2 hours post dose luteinizing releasing hormone IV


name: 30 minutes post dose growth hormone releasing factor


name: 30 minutes post dose luteinizing releasing hormone IV


name: 45 minutes post dose growth hormone releasing factor


name: 7 minutes post 0.5 ug/kg pentagastrin IV


name: 8 hours post 8 mg dexamethasone PO overnight high dose


name: post 2 mg dexamethasone PO 2.5 day high dose q6h


name: post 500 ug dexamethasone PO 2.5 day low dose q6h


name: pre 100 ug luteinizing releasing hormone IV


name: pre dose growth hormone releasing factor


name: pre dose luteinizing releasing hormone IV


name: Bacterial vaginosis & vaginitis rRNA panel


name: Date determined medically eligible and ready to start HIV Rx


name: Date determined medically eligible to start HIV Rx


name: Trisomy 21 risk based on maternal age + Alpha-1-Fetoprotein + Choriogonadotropin + Estriol.unconjugated


name: Guidance for aspiration or injection of cyst


name: Guidance for change of percutaneous tube


name: Guidance for percutaneous replacement of drainage catheter


name: human immunodeficiency virus care & family status section


name: Medication or other side effects associated with HIV Rx


name: Multisection sagittal & coronal disarticulation


name: Outpatient encounter-level information section


name: Reason for stopping human immunodeficiency virus Rx


name: Rheumatoid factor & Cyclic citrullinated peptide Ab.IgG panel


name: Severity of side effect to human immunodeficiency virus Rx


name: Symptom, diagnosis, or opportunistic infection related to HIV Rx


name: TCRB & Immunoglobulin heavy chain gene rearrangements


name: Nucleic acid amplification detection limit = 200 copies/ml


name: Outcome and Assessment Information Survey set


name: Aware of normal hazards & take appropriate precautions:Find:Pt:^Patient:Ord:RFC assessment


name: Aware of normal hazards & take appropriate precautions


name: Travels in unfamiliar places or use public transportation:Find:Pt:^Patient:Ord:RFC assessment


name: Travels in unfamiliar places or use public transportation


name: Sets realistic goals or make plans independently of others:Find:Pt:^Patient:Ord:RFC assessment


name: Sets realistic goals or make plans independently of others


name: Functional capacity assessment:Find:Pt:^Patient:Nar:RFC assessment


name: Residual physical functional capacity (RFC) assessment form:-:Pt:^Patient:-:RFC assessment


name: Residual physical functional capacity (RFC) assessment form


name: IP CDB claim numberholder:ID:Pt:^Patient:Nom:RFC assessment


name: Follow-up contact supplemental information


name: Outcome and Assessment Information Set (OASIS)


name: Residual Functional Capacity Assessment (RFC)


name: Vasopressin^1st specimen post XXX challenge:MCnc:Pt:Plas:Qn


name: Chlamydia trachomatis L2 DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Cholesterol.in LDL real size pattern:Prid:Pt:Ser/Plas:Nom


name: Hepatitis B virus DNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar detection limit = 200 copies/mL


name: Hepatitis C virus Ab:PrThr:Pt:Ser^Donor:Ord:IA


name: Views GE 4 && Views:Find:Pt:Chest:Doc:XR && RF


name: Views GE 4 + PA + lateral:Find:Pt:Chest:Doc:XR


name: Multisection blood pool^W radionuclide IV:Find:Pt:Abdomen>Liver:Doc:NM.SPECT


name: Guidance for change of percutaneous tube^W contrast:Find:Pt:XXX:Doc:XR


name: Guidance for percutaneous drainage+placement of drainage catheter:Find:Pt:Abdomen>Biliary ducts:Doc:RF


name: Guidance for placement of tube^W radionuclide IV:Find:Pt:Chest:Doc:NM.SPECT


name: Views PA^W standing + W flexion:Find:Pt:Lower extremity.bilateral>Knee:Doc:XR


name: Multisection:Find:Pt:Upper extremity.bilateral>Upper extremity vessels:Doc:US.doppler


name: ABO & Rh group^post transfusion reaction:Type:Pt:Bld^BPU:Nom


name: ABO group^post transfusion reaction:Type:Pt:Bld:Nom


name: Blood group antibody^post transfusion reaction:PrThr:Pt:Ser/Plas:Ord:Blood group antibody screen


name: Xylose^15M post 25 g xylose PO:MCnc:Pt:Ser/Plas:Qn


name: Norepinephrine^4th specimen post XXX challenge:SCnc:Pt:Urine:Qn


name: Norepinephrine^5th specimen post XXX challenge:SCnc:Pt:Plas:Qn


name: Norepinephrine^5th specimen post XXX challenge:SCnc:Pt:Urine:Qn


name: Norepinephrine^6th specimen post XXX challenge:SCnc:Pt:Plas:Qn


name: Norepinephrine^6th specimen post XXX challenge:SCnc:Pt:Urine:Qn


name: Catecholamines^7th specimen post XXX challenge:SCnc:Pt:Plas:Qn


name: Norepinephrine^7th specimen post XXX challenge:SCnc:Pt:Urine:Qn


name: Mycobacterium tuberculosis tuberculin stimulated gamma interferon/Mitogen stimulated gamma interferon:ACnc:Pt:Bld^Control:Qn


name: Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells:ACnc:Pt:Bld:Qn


name: Coagulation:Time:Pt:PPP:Qn:Coag.thrombin induced.after addition of heparinase


name: ABCA3 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: SGCA gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Chief complaint+Reason for visit:Find:Pt:^Patient:Nar


name: Mycobacterium tuberculosis complex rpoB gene rifAMPin resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Mycobacterium tuberculosis pncA gene pyrazinamide resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Mycobacterium tuberculosis katG gene isoniazid high level resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Mycobacterium tuberculosis embB gene ethambutol resistance mutation:Prid:Pt:Isolate/Specimen:Nom:Molgen


name: Borrelia burgdorferi Ab.IgG & IgM:Imp:Pt:Ser:Nom:IA


name: Bordetella pertussis.filamentous hemagglutinin Ab.IgG:ACnc:Pt:Ser:Qn:IF


name: Bordetella pertussis.pertussis toxin Ab.IgG:ACnc:Pt:Ser:Qn:IF


name: History of medical device use:Find:Pt:{Setting}:Doc:{Role}


name: Direct antiglobulin test.polyspecific reagent^post transfusion reaction:PrThr:Pt:RBC:Ord


name: Major crossmatch^post transfusion reaction:Imp:Pt:Ser/Plas:Nom


name: Rh immune globulin given by:ID:Pt:Provider:Nom


name: Views for bone density:ArMass:Pt:Lower extremity.left>Hip:Qn:DXA


name: Views for bone density:ArMass:Pt:Lower extremity.right>Hip:Qn:DXA


name: Deprecated Radius & Ulna right DEXA Bone density


name: Guidance for aspiration or injection of cyst:Find:Pt:XXX:Doc:CT


name: Guidance for aspiration or injection of cyst:Find:Pt:XXX:Doc:US


name: Guidance for percutaneous aspiration.fine needle:Find:Pt:Breast.right:Doc:MG


name: Guidance for percutaneous aspiration.fine needle:Find:Pt:Breast.left:Doc:MG


name: Guidance for biopsy.core needle:Find:Pt:Neck>Thyroid gland:Doc:US


name: Deprecated CT Guidance for needle biopsy of Unspecified body region


name: Guidance for percutaneous biopsy^WO & W contrast IV:Find:Pt:XXX:Doc:CT


name: Guidance for percutaneous biopsy^WO contrast:Find:Pt:XXX:Doc:CT


name: Guidance for drainage+placement of drainage catheter^WO & W contrast IV:Find:Pt:XXX:Doc:CT


name: Guidance for drainage+placement of drainage catheter^W contrast IV:Find:Pt:XXX:Doc:CT


name: Guidance for drainage+placement of drainage catheter^WO contrast:Find:Pt:XXX:Doc:CT


name: Guidance for percutaneous replacement of drainage catheter:Find:Pt:Abdomen>Stomach:Doc:RF


name: Guidance for percutaneous biopsy.core needle:Find:Pt:Breast.left:Doc:MG.stereotactic


name: Guidance for percutaneous biopsy.core needle:Find:Pt:Breast:Doc:MG.stereotactic


name: Multisection^W radionuclide IV:Find:Pt:Whole body:Doc:NM.SPECT


name: Multisection limited:Find:Pt:Upper extremity.bilateral>Upper extremity artery:Doc:US.doppler


name: Multisection limited:Find:Pt:Upper extremity>Upper extremity vessels:Doc:US.doppler


name: Multisection^W contrast IV:Find:Pt:Whole body:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.right>Lower extremity vessels:Doc:CT.angio


name: Multisection^WO & W contrast IV:Find:Pt:Lower extremity.left>Lower extremity vessels:Doc:CT.angio


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.right>Upper extremity vessels:Doc:CT.angio


name: Multisection^WO & W contrast IV:Find:Pt:Head>Orbit+Face & Neck:Doc:MR


name: Multisection^WO & W contrast IV:Find:Pt:Neck>Parotid gland:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Upper extremity.left>Upper extremity vessels:Doc:CT.angio


name: Multisection^WO & W reduced contrast volume IV:Find:Pt:Pelvis:Doc:CT


name: Multisection^WO & W reduced contrast volume IV:Find:Pt:Head>Internal auditory canal:Doc:CT


name: Multisection^WO & W reduced contrast volume IV:Find:Pt:Head>Maxillofacial region:Doc:CT


name: Multisection^WO & W reduced contrast volume IV:Find:Pt:Head:Doc:CT


name: Multisection^WO & W reduced contrast volume IV:Find:Pt:Chest:Doc:CT


name: Multisection^WO & W reduced contrast volume IV:Find:Pt:Abdomen:Doc:CT


name: Multisection^W contrast IS:Find:Pt:Upper extremity>Elbow:Doc:MR


name: Multisection^W contrast IV:Find:Pt:Head>Orbit+Face & Neck:Doc:MR


name: Multisection^W contrast IV:Find:Pt:Lower extremity>Lower extremity vessels:Doc:MR.angio


name: Multisection^W reduced contrast volume IV:Find:Pt:Head>Internal auditory canal:Doc:CT


name: Multisection^W reduced contrast volume IV:Find:Pt:Head>Maxillofacial region:Doc:CT


name: Multisection^W reduced contrast volume IV:Find:Pt:Chest:Doc:CT


name: Multisection^W reduced contrast volume IV:Find:Pt:Head:Doc:CT


name: Multisection^W reduced contrast volume IV:Find:Pt:Pelvis:Doc:CT


name: Multisection^W reduced contrast volume IV:Find:Pt:Abdomen:Doc:CT


name: Multisection^WO contrast:Find:Pt:Head>Orbit+Face & Neck:Doc:MR


name: Views GE 3:Find:Pt:Upper extremity.right>Wrist:Doc:XR


name: Views GE 3:Find:Pt:Upper extremity.left>Elbow:Doc:XR


name: Views GE 3:Find:Pt:Upper extremity.right>Elbow:Doc:XR


name: Views GE 3:Find:Pt:Upper extremity.left>Wrist:Doc:XR


name: Views GE 3:Find:Pt:Lower extremity.right>Ankle:Doc:XR


name: Views GE 2 + PA + lateral:Find:Pt:Chest:Doc:XR


name: Views AP + transthoracic:Find:Pt:Upper extremity.bilateral>Shoulder:Doc:XR


name: Views displacement for implant:Find:Pt:Breast.bilateral:Doc:MG


name: Views^during surgery W contrast intra duct:Find:Pt:Breast>Breast duct:Doc:MG


name: Views^W air contrast PR:Find:Pt:Abdomen+Pelvis>Colon:Doc:RF


name: Multisection^WO & W contrast IV:Find:Pt:Chest>Aortic arch:Doc:MR.angio


name: Views ventilation^W Xe-133 IH:Find:Pt:Chest>Lung:Doc:NM


name: Multisection:Find:Pt:Lower extremity>Lower extremity vein:Doc:US


name: Multisection:Find:Pt:Lower extremity.bilateral>Lower extremity vein:Doc:US


name: Guidance for ablation of tissue:Find:Pt:Abdomen>Celiac plexus:Doc:CT


name: Guidance for percutaneous biopsy^W radionuclide IV:Find:Pt:XXX>Bone:Doc:NM.SPECT


name: Views for bone density:ArMass:Pt:XXX>Bone:Qn:DXA


name: Guidance for superficial biopsy^W radionuclide IV:Find:Pt:XXX>Bone:Doc:NM.SPECT


name: Multisection for graft:Find:Pt:Upper extremity>Upper extremity vessel:Doc:US.doppler


name: Guidance for percutaneous aspiration.fine needle:Find:Pt:Breast:Doc:MG


name: Views GE 3:Find:Pt:Lower extremity.left>Ankle:Doc:XR


name: Multisection gated+ejection fraction^at rest+W stress+W radionuclide IV:Find:Pt:Chest>Heart:Doc:NM.SPECT


name: Multisection gated^at rest+W Tc-99m Sestamibi IV:Find:Pt:Chest>Heart:Doc:NM.SPECT


name: Cortisol^15M post 1 ug/kg CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^1.5H post 1 ug/kg CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^2H post 1 ug/kg CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Corticotropin^15M post 1 ug/kg CRH IV:MCnc:Pt:Plas:Qn


name: Corticotropin^1.5H post 1 ug/kg CRH IV:MCnc:Pt:Plas:Qn


name: Corticotropin^2H post 1 ug/kg CRH IV:MCnc:Pt:Plas:Qn


name: Cortisol^2H post dose insulin IV:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^2H post dose insulin IV:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^30M pre 1 g/kg glucose PO:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^30M post 1 g/kg glucose PO:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^1.5H post 1 g/kg glucose PO:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^15M pre dose arginine:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^15M post dose arginine:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^30M post dose arginine:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^45M post dose arginine:MCnc:Pt:Ser/Plas:Qn


name: Somatotropin^105M post dose arginine:MCnc:Pt:Ser/Plas:Qn


name: Calcitonin^7M post 0.5 ug/kg pentagastrin IV:MCnc:Pt:Ser/Plas:Qn


name: Lutropin^15M post dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn


name: Lutropin^45M post dose gonadotropin releasing hormone:ACnc:Pt:Ser/Plas:Qn


name: Cortisol^8H post 8 mg dexamethasone PO overnight high dose:MCnc:Pt:Ser/Plas:Qn


name: Hydrogen/Expired gas^post 50 g lactose PO:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^post 10 g lactulose PO:VFr:Pt:Exhl gas:Qn


name: t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen


name: Rheumatoid factor & Cyclic citrullinated peptide Ab.IgG:Imp:Pt:Ser:Nom


name: Rheumatoid factor & Cyclic citrullinated peptide Ab.IgG panel:ACnc:Pt:Ser:Qn


name: Cancer identification section:-:Pt:^Patient:Set:NAACCR v.11


name: Edit overrides &or Conversion history &or System admin section:-:Pt:^Patient:Set:NAACCR v.11


name: Edit overrides &or Conversion history &or System admin section


name: Follow-up &or Recurrence &or Death section:-:Pt:^Patient:Set:NAACCR v.11


name: Follow-up &or Recurrence &or Death section


name: Record ID section:-:Pt:^Patient:Set:NAACCR v.11


name: Special use section:-:Pt:^Patient:Set:NAACCR v.11


name: Stage &or prognostic factors section:-:Pt:^Patient:Set:NAACCR v.11


name: Treatment-1st course section:-:Pt:^Patient:Set:NAACCR v.11


name: Treatment-subsequent & other section:-:Pt:^Patient:Set:NAACCR v.11


name: Shigella sp:PrThr:Pt:XXX:Ord:Organism specific culture


name: Changed medical regimen diagnoses:-:Pt:^Patient:-


name: Number of pressure injuries at each stage:-:Pt:^Patient:-


name: Number of pressure injuries at each stage


name: Deprecated Outcome and assessment information set (OASIS) form - version B1


name: Current payment sources for home care:Find:Pt:^Patient:Nom:OASIS


name: Conditions prior to medical or treatment regimen change or inpatient stay within past 14D:Find:14D:^Patient:Nom:OASIS


name: Conditions prior to medical or treatment regimen change or inpatient stay within past 14D


name: Therapeutic substance administered at home:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Assisting person(s) other than home care agency staff:Find:Pt:^Patient:Nom:OASIS


name: Assisting person(s) other than home care agency staff


name: Type of primary caregiver assistance:-:Pt:^Patient:-


name: At home respiratory treatments:Find:Pt:^Patient:Nom:OASIS


name: Cognitive, behavioral, and psychiatric symptoms demonstrated at least one time per W:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Behaviors demonstrated at least once a week


name: Discharge support services or assistance:Find:Pt:^Patient:Nom:OASIS


name: Discharge support services or assistance


name: Reason for nursing home admission:Find:Pt:^Patient:Nom:OASIS


name: Ability to dress upper body:-:Pt:^Patient:-


name: Ability to dress lower body:-:Pt:^Patient:-


name: Planning & preparing light meals:-:Pt:^Patient:-


name: Ability to use telephone:-:Pt:^Patient:-


name: Management of oral medications:-:Pt:^Patient:-


name: Management of inhalant &or mist medications:-:Pt:^Patient:-


name: Management of inhalant &or mist medications


name: State location of agency branch:Loc:RptPeriod:Agency:Nom:CMS Assessment


name: Agency patient number:ID:RptPeriod:^Patient:Nom:CMS Assessment


name: Start of care date:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Resumption of care date:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Discipline of person completing assessment:Type:RptPeriod:Provider:Nom:CMS Assessment


name: Discipline of person completing assessment


name: Date assessment information completed:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Deprecated Most recent inpatient discharge date [OASIS]


name: Inpatient stay within last 14D - ICD code:Prid:14D:^Patient:Nom:CMS Assessment


name: Inpatient stay within last 14D - ICD code^^^2:Prid:14D:^Patient:Nom:OASIS


name: Medical or treatment regimen change in past 14D:Find:14D:^Patient:Ord:OASIS


name: Medical or treatment regimen change in past 14D


name: Regimen change in past 14D - ICD code:Prid:14D:^Patient:Nom:CMS Assessment


name: Regimen change in past 14D - ICD code^^^2:Prid:14D:^Patient:Nom:OASIS


name: Regimen change in past 14D - ICD code^^^3:Prid:14D:^Patient:Nom:OASIS


name: Regimen change in past 14D - ICD code ^^^4:Prid:14D:^Patient:Nom:OASIS


name: Primary diagnosis severity rating:Find:Pt:^Patient:Ord:OASIS


name: Other diagnosis 1 - ICD code:Prid:Pt:^Patient:Nom:OASIS


name: Other diagnosis 1 - severity rating:Find:Pt:^Patient:Ord:OASIS


name: Other diagnosis 2 - ICD code:Prid:Pt:^Patient:Nom:OASIS


name: Other diagnosis 2 - severity rating:Find:Pt:^Patient:Ord:OASIS


name: Other diagnosis 3 - ICD code:Prid:Pt:^Patient:Nom:OASIS


name: Other diagnosis 3 - severity rating:Find:Pt:^Patient:Ord:OASIS


name: Other diagnosis 4 - ICD code:Prid:Pt:^Patient:Nom:OASIS


name: Other diagnosis 4 - severity rating:Find:Pt:^Patient:Ord:OASIS


name: Other diagnosis 5 - ICD code:Prid:Pt:^Patient:Nom:OASIS


name: Other diagnosis 5 - severity rating:Find:Pt:^Patient:Ord:OASIS


name: Overall prognosis for recovery from this episode:Find:Pt:^Patient:Ord:OASIS


name: Overall prognosis for recovery from this episode


name: Frequency of primary caregiver assistance:Find:Pt:^Patient:Ord:OASIS


name: Frequency of primary caregiver assistance


name: Sensory status - vision:Find:Pt:^Patient:Ord:OASIS


name: Sensory status - hearing and ability to understand spoken language:Find:Pt:^Patient:Ord:OASIS


name: Sensory status - speech and oral expression of language:Find:Pt:^Patient:Ord:OASIS


name: Sensory status - frequency of pain:Find:Pt:^Patient:Ord:OASIS


name: Skin lesion or open wound:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Number of pressure injuries - stage 1:Num:RptPeriod:^Patient:Ord:CMS Assessment


name: Number of pressure ulcers - stage 2:Num:Pt:^Patient:Qn:OASIS


name: Number of pressure ulcers - stage 3:Num:Pt:^Patient:Qn:OASIS


name: Number of pressure ulcers - stage 4:Num:Pt:^Patient:Qn:OASIS


name: Stage of most problematic pressure injury:Find:Pt:^Patient:Ord:OASIS


name: Status of most problematic pressure injury:Find:Pt:^Patient:Ord:OASIS


name: Number of stasis ulcers:Num:Pt:^Patient:Qn:OASIS


name: Unobserved stasis pressure injury:Find:Pt:^Patient:Ord:OASIS


name: Status of most problematic stasis pressure injury:Find:Pt:^Patient:Ord:OASIS


name: Status of most problematic stasis pressure injury


name: Number of surgical wounds:Num:Pt:^Patient:Qn:OASIS


name: Status of most problematic surgical wound:Find:Pt:^Patient:Ord:OASIS


name: Status of most problematic surgical wound


name: When short of breath:Find:Pt:^Patient:Ord:OASIS


name: Treated for urinary tract infection in past 14D:Find:14D:^Patient:Ord:CMS Assessment


name: Treated for urinary tract infection in past 14D


name: Urinary incontinence or urinary catheter present:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Urinary incontinence or urinary catheter present


name: Current ability - ambulation:Find:Pt:^Patient:Ord:OASIS


name: Current ability - feeding:Find:Pt:^Patient:Ord:OASIS


name: Prior - prepare light meals:Find:Pt:^Patient:Ord:OASIS


name: Current ability - prepare light meals:Find:Pt:^Patient:Ord:OASIS


name: Current ability - transportation:Find:Pt:^Patient:Ord:OASIS


name: Current ability - laundry:Find:Pt:^Patient:Ord:OASIS


name: Current ability - housekeeping:Find:Pt:^Patient:Ord:OASIS


name: Current ability - shopping:Find:Pt:^Patient:Ord:OASIS


name: Prior - telephone use:Find:Pt:^Patient:Ord:OASIS


name: Telephone use - functional ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Prior - management of oral medications:Find:Pt:^Patient:Ord:OASIS


name: Current ability - management of oral medications:Find:Pt:^Patient:Ord:OASIS


name: Prior - management of inhalant medications:Find:Pt:^Patient:Ord:OASIS


name: Current ability - management of inhalant medications:Find:Pt:^Patient:Ord:OASIS


name: Prior - management of injectable medications:Find:Pt:^Patient:Ord:OASIS


name: Prior - management of injectable medications


name: Current ability - management of injectable medications:Find:Pt:^Patient:Ord:OASIS


name: Admitted to:Type:RptPeriod:Inpatient facility:Nom:CMS Assessment


name: Acute care hospitalization reason:Find:Pt:^Patient:Ord:OASIS


name: Date of last home visit:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Discharge, transfer, death date:Date:Pt:^Patient:Qn


name: Payment diagnosis - primary ICD code:Prid:Pt:^Patient:Nom:OASIS


name: Payment diagnosis - first secondary ICD:Prid:Pt:^Patient:Nom:OASIS


name: When urinary incontinence occurs:Find:Pt:^Patient:Ord:OASIS


name: Bowel incontinence frequency:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Ostomy for bowel elimination:Find:Pt:^Patient:Ord:OASIS


name: Frequency of behavior problems:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Receives psychiatric nursing:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Grooming - functional ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Prior - dress upper body:Find:Pt:^Patient:Ord:OASIS


name: Dress upper body - functional ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Prior - dress lower body:Find:Pt:^Patient:Ord:OASIS


name: Dress lower body - functional ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Current ability - bathing:Find:Pt:^Patient:Ord:OASIS


name: Current ability - toileting:Find:Pt:^Patient:Ord:OASIS


name: Current ability - transferring:Find:Pt:^Patient:Ord:OASIS


name: Primary referring physician ID:ID:Pt:Provider:Nom


name: Diagnosis and severity index:-:Pt:^Patient:-


name: Mental residual functional capacity (RFC) assessment form:-:Pt:^Patient:-


name: Mental residual functional capacity (RFC) assessment form


name: Remembers locations & worklike procedures:Find:Pt:^Patient:Ord:RFC assessment


name: Remembers locations & worklike procedures


name: Understands & remembers very short & simple instructions:Find:Pt:^Patient:Ord:RFC assessment


name: Understands & remembers very short & simple instructions


name: Understands & remembers detailed instructions:Find:Pt:^Patient:Ord:RFC assessment


name: Understands & remembers detailed instructions


name: Carries out very short & simple instructions:Find:Pt:^Patient:Ord:RFC assessment


name: Carries out very short & simple instructions


name: Carries out detailed instructions:Find:Pt:^Patient:Ord:RFC assessment


name: Maintains attention & concentration for extended periods:Find:Pt:^Patient:Ord:RFC assessment


name: Maintains attention & concentration for extended periods


name: Performs activities within a schedule, maintains regular attendance, is punctual within customary tolerances:Find:Pt:^Patient:Ord:RFC assessment


name: Performs activities within a schedule, maintains regular attendance, is punctual within customary tolerances


name: Sustains an ordinary routine without special supervision:Find:Pt:^Patient:Ord:RFC assessment


name: Sustains an ordinary routine without special supervision


name: Works in coordination with or proximity to others without being distracted by them:Find:Pt:^Patient:Ord:RFC assessment


name: Works in coordination with or proximity to others without being distracted by them


name: Makes simple work-related decisions:Find:Pt:^Patient:Ord:RFC assessment


name: Completes normal workday & week WO interruptions from psych symptoms & performs at consistent pace WO unreasonable number & length of rests:Find:Pt:^Patient:Ord:RFC assessment


name: Completes normal workday & week WO interruptions from psych symptoms & performs at consistent pace WO unreasonable number & length of rests


name: Interacts appropriately with the general public:Find:Pt:^Patient:Ord:RFC assessment


name: Interacts appropriately with the general public


name: Asks simple questions or request assistance:Find:Pt:^Patient:Ord:RFC assessment


name: Asks simple questions or request assistance


name: Accepts instructions & respond appropriately to criticism from supervisors:Find:Pt:^Patient:Ord:RFC assessment


name: Accepts instructions & respond appropriately to criticism from supervisors


name: Gets along with coworkers or peers WO distracting them or exhibiting behavioral extremes:Find:Pt:^Patient:Ord:RFC assessment


name: Gets along with coworkers or peers WO distracting them or exhibiting behavioral extremes


name: Maintains socially appropriate behavior & adheres to basic standards of neatness & cleanliness:Find:Pt:^Patient:Ord:RFC assessment


name: Maintains socially appropriate behavior & adheres to basic standards of neatness & cleanliness


name: Responds appropriately to changes in the work setting:Find:Pt:^Patient:Ord:RFC assessment


name: Responds appropriately to changes in the work setting


name: Other alleged impairments:Imp:Pt:^Patient:Nar:RFC assessment


name: No exertional limitations:Arb:Pt:^Patient:Ord:RFC assessment


name: Occasionally lift &or carry:Find:Pt:^Patient:Ord:RFC assessment


name: Frequently lift &or carry:Find:Pt:^Patient:Ord:RFC assessment


name: Stand &or walk:Find:Pt:^Patient:Ord:RFC assessment


name: Push &or pull:Find:Pt:^Patient:Ord:RFC assessment


name: No postural limitations:Arb:Pt:^Patient:Ord:RFC assessment


name: No manipulative limitations:Arb:Pt:^Patient:Ord:RFC assessment


name: Reaching in all directions:Find:Pt:^Patient:Ord:RFC assessment


name: No visual limitations:Arb:Pt:^Patient:Ord:RFC assessment


name: Field of vision:Find:Pt:^Patient:Ord:RFC assessment


name: No communicative limitations:Arb:Pt:^Patient:Ord:RFC assessment


name: Fumes, odors, dusts, gases, poor ventilation, etc:Find:Pt:^Patient:Ord:RFC assessment


name: Fumes, odors, dusts, gases, poor ventilation, etc


name: Treatment or examining source statements:-:Pt:^Patient:Set:RFC assessment


name: Treatment or examining source statements


name: Treating or examining source statement regarding claimant's physical capacities in file:Arb:Pt:^Patient:Ord:RFC assessment


name: Treating or examining source statement regarding claimant's physical capacities in file


name: Treating or examining source conclusions about the claimant's limitations or restrictions which are significantly different from your file:Arb:Pt:^Patient:Nom:RFC assessment


name: Treating or examining source conclusions about the claimant's limitations or restrictions which are significantly different from your file


name: Why conclusions are not supported by the evidence in file:Imp:Pt:^Patient:Nar:RFC assessment


name: Why conclusions are not supported by the evidence in file


name: Fibroblast growth factor 23:ACnc:Pt:Plas:Qn


name: Clostridium botulinum toxin gene:Prid:Pt:XXX:Nom:Probe.amp.tar


name: Clostridium perfringens toxin gene:Prid:Pt:XXX:Nom:Probe.amp.tar


name: (Anacardium occidentale+Carya illinoinensis+Juglans spp+Pistacia vera) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Arachis hypogaea+Bertholletia excelsa+Cocos nucifera+Corylus avellana+Prunus dulcis) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Artemisia vulgaris+Chenopodium album+Plantago lanceolata+Solidago virgaurea+Urtica dioica) Ab.IgE:MCnc:Pt:Ser:Qn:Multidisk


name: (Beef+Chicken meat+Pork+Turkey meat) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Brassica oleracea var italica+Daucus carota+Phaseolus vulgaris+Pisum sativum+Zea mays) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Gadus morhua+Mytilus edulis+Pandalus borealis+Salmo salar+Thunnus albacares) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Hordeum vulgare+Oryza sativa+Secale cereale+Triticum aestivum) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: (Malus sylvestris+Musa spp+Prunus persica+Pyrus communis) Ab.IgE:ACnc:Pt:Ser:Qn:Multidisk


name: Coagulation:Time:Pt:PPP:Qn:Coag.thrombin induced.factor substitution.immediately after addition of bovine thrombin


name: Aquaporin 4 water channel Ab.IgG:PrThr:Pt:CSF:Ord


name: Streptomycin:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria.antibiotic concentration at 4.0 ug/mL


name: HTR2A gene+HTR2C gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Deprecated Prolactin monomeric [Mass/volume] in Serum or Plasma


name: Bacterial vaginosis whiff test:PrThr:Pt:Vag:Ord


name: RHCE gene allele Cc:Geno:Pt:Amnio fld:Nom:Molgen


name: Citrullinemias &or arginosuccinic aciduria:Imp:Pt:Bld.dot:Nom


name: Fatty acid oxidation defects:Imp:Pt:Bld.dot:Nom


name: Glutaric acidemia type 1:Imp:Pt:Bld.dot:Nom


name: Homocystinuria &or other hypermethioninemias:Imp:Pt:Bld.dot:Ord


name: Isovaleric acidemia &or 2-Methylbutyric acidemia:Imp:Pt:Bld.dot:Nom


name: Maple syrup urine disease:Imp:Pt:Bld.dot:Nom


name: Phenylketonuria and variants &or biopterin defects:Imp:Pt:Bld.dot:Nom


name: Propionic &or methylmalonic acidemias:Imp:Pt:Bld.dot:Nom


name: 3-Methylcrotonic &or hydroxymethylglutaric &or methylglutaconic:Imp:Pt:Bld.dot:Ord


name: 2-Methyl-3-Hydroxybutyric acidemias &or beta ketothiolase deficiency:Imp:Pt:Bld.dot:Nom


name: Medium chain acyl dehydrogenase deficiency &or glutaric acidemia type 2:Imp:Pt:Bld.dot:Ord


name: Very long chain hydroxy acyl dehydrogenase deficiency:Imp:Pt:Bld.dot:Nom


name: Long chain hydroxy acyl dehydrogenase &or trifunctional protein deficiencies:Imp:Pt:Bld.dot:Nom


name: Carnitine uptake defect &or CPT1 deficiency:Imp:Pt:Bld.dot:Ord


name: Other fatty acid oxidation disorders:Imp:Pt:Bld.dot:Ord


name: Hb SS, Hb SC, Hb SB thal:Imp:Pt:Bld.dot:Ord


name: Thyroid binding globulin deficiency:Imp:Pt:Bld.dot:Ord


name: Hemoglobin S beta thalassemia:Imp:Pt:Bld.dot:Ord


name: Sickle cell carrier (trait):Imp:Pt:Bld.dot:Ord


name: Carnitine palmitoyltransferase 1 deficiency:Imp:Pt:Bld.dot:Nom


name: Glutaric acidemia 2 &or ethylmalonic encephalopathy:Imp:Pt:Bld.dot:Nom


name: Medium &or short chain acyl-CoA dehydrogenase deficiency:Imp:Pt:Bld.dot:Nom


name: Short-chain acyl-CoA deficiency &or ethylmalonic encephalopathy &or isobutyryl-CoA dehydrogenase deficiency:Imp:Pt:Bld.dot:Nom


name: Communicable &or infectious condition function.behavior:Find:Pt:^Community:Ord:Observed.OMAHA


name: Communicable &or infectious condition function.knowledge:Find:Pt:^Community:Ord:Observed.OMAHA


name: Communicable &or infectious condition function.status:Find:Pt:^Community:Ord:Observed.OMAHA


name: Communication with community resources.behavior:Find:Pt:^Community:Ord:Observed.OMAHA


name: Communication with community resources.knowledge:Find:Pt:^Community:Ord:Observed.OMAHA


name: Communication with community resources.status:Find:Pt:^Community:Ord:Observed.OMAHA


name: Neighborhood &or workplace safety.behavior:Find:Pt:^Community:Ord:Observed.OMAHA


name: Neighborhood &or workplace safety.knowledge:Find:Pt:^Community:Ord:Observed.OMAHA


name: Neighborhood &or workplace safety.status:Find:Pt:^Community:Ord:Observed.OMAHA


name: Sleep and rest pattern.behavior:Find:Pt:^Community:Ord:Observed.OMAHA


name: Sleep and rest pattern.knowledge:Find:Pt:^Community:Ord:Observed.OMAHA


name: Sleep and rest pattern.status:Find:Pt:^Community:Ord:Observed.OMAHA


name: Communicable &or infectious condition function.behavior:Find:Pt:^Family:Ord:Observed.OMAHA


name: Communicable &or infectious condition function.knowledge:Find:Pt:^Family:Ord:Observed.OMAHA


name: Communicable &or infectious condition function.status:Find:Pt:^Family:Ord:Observed.OMAHA


name: Communicable &or infectious condition function.behavior:Find:Pt:^Patient:Ord:Observed.OMAHA


name: Communicable &or infectious condition function.knowledge:Find:Pt:^Patient:Ord:Observed.OMAHA


name: Communicable &or infectious condition function.status:Find:Pt:^Patient:Ord:Observed.OMAHA


name: TCR alpha beta Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: TCR gamma delta Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Vasoactive intestinal peptide Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: MCOLN1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Haemophilus influenzae B Ab.IgG^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn


name: Haemophilus influenzae B Ab.IgG^1st specimen:MCnc:Pt:Ser:Qn:IA


name: Haemophilus influenzae B Ab.IgG^2nd specimen:MCnc:Pt:Ser:Qn:IA


name: Influenza virus A Ab.IgM:ACnc:Pt:Ser:Qn:IA


name: Influenza virus A Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: Influenza virus B Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: Influenza virus B Ab.IgM:ACnc:Pt:Ser:Qn:IA


name: Views GE 3:Find:Pt:Upper extremity.left>Hand:Doc:XR


name: Views GE 3:Find:Pt:Upper extremity.right>Hand:Doc:XR


name: Views 1 or 2:Find:Pt:Lower extremity.left>Knee:Doc:XR


name: Views GE 4:Find:Pt:Lower extremity.left>Knee:Doc:XR


name: Views 1 or 2:Find:Pt:Lower extremity.right>Knee:Doc:XR


name: Views GE 4:Find:Pt:Lower extremity.right>Knee:Doc:XR


name: Views LE 4:Find:Pt:Lower extremity.right>Knee:Doc:XR


name: Liver kidney microsomal Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: GBA gene mutations tested for:Prid:Pt:Bld/Tiss:Nom:Molgen


name: CFTR gene targeted mutation analysis:Find:Pt:Amnio fld:Doc:Molgen


name: ASPA gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: BLM gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: DYS gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: TCRB & Immunoglobulin heavy chain gene rearrangements:Find:Pt:Bld/Tiss:Doc:Molgen


name: Bacterial vaginosis & vaginitis rRNA panel:-:Pt:Vag:-:Probe


name: Varicella zoster virus DNA:NCnc:Pt:CSF:Qn:Probe.amp.tar


name: Varicella zoster virus DNA:NCnc:Pt:Ser/Plas:Qn:Probe.amp.tar


name: Cancer Ag 72-4:PrThr:Pt:Tiss:Ord:Immune stain


name: Choriogonadotropin.beta subunit Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Cytokeratin 5+6 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Cytokeratin HMW Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Streptococcus pneumoniae Danish serotype 9V Ab.IgG^2nd specimen/1st specimen:Ratio:Pt:Ser:Qn:IA


name: Admission history and physical note:Find:Pt:Hospital:Doc:{Role}


name: Summary of death note:Find:Pt:{Setting}:Doc:{Role}


name: Diagnostic interventional radiology study:Find:Pt:^Patient:Doc:Interventional radiology


name: Herpes virus 8 Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 10 Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 11 Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 11 Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 12 Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 12 Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 13 Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 13 Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 14 Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 14 Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Epstein Barr virus capsid Ab.IgG:Titr:Pt:Body fld:SemiQn:IF


name: Epstein Barr virus capsid Ab.IgM:Titr:Pt:Body fld:SemiQn:IF


name: Epstein Barr virus early Ab.IgG:Titr:Pt:Body fld:SemiQn:IF


name: Epstein Barr virus early Ab.IgA:Titr:Pt:Ser:SemiQn:IF


name: PCNA extractable nuclear Ab:PrThr:Pt:Ser:Ord:IF


name: Coxiella burnetii phase 1 Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 7 Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 7 Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 8 Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 8 Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 9 Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 9 Ab.IgM:Titr:Pt:Ser:SemiQn:IF


name: Legionella pneumophila 10 Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Platelet glycoprotein Ia-IIa Ab:PrThr:Pt:Ser:Ord:IA


name: Epinephrine^1H post 300 ug cloNIDine PO:SCnc:Pt:Plas:Qn


name: Epinephrine^2H post 300 ug cloNIDine PO:SCnc:Pt:Plas:Qn


name: EPINEPHrine^2H post XXX challenge:SCnc:Pt:Plas:Qn


name: EPINEPHrine^2nd specimen post XXX challenge:SCnc:Pt:Plas:Qn


name: EPINEPHrine^2nd specimen post XXX challenge:SCnc:Pt:Urine:Qn